The Latest Breaking News from Matthew Kacsmaryk

The Supreme Court has left the case in the hands of the 5th U.S. Circuit Court of Appeals, which has scheduled oral arguments in the case for May 17.

Federal judge in Texas ruled in early April to suspend FDA-approved mifepristone used in more than half of abortions in US

The legal challenge to mifepristone now returns to the 5th U.S. Circuit Court of Appeals in New Orleans.

The ruling preserves broad access to mifepristone, while litigation continues over the pill’s approval for US use.

The Supreme Court weighs in on a case involving a drug commonly used for abortions that the FDA first approved in 2000.

The US Supreme Court is considering whether to uphold restrictions to the pill used in more than half of US abortions.

The US Supreme Court has ruled on a challenge to mifepristone pills, the most common method in the US, which was brought by anti-abortion campaigners in the first abortion controversy to reach the nation's highest court since its conservative majority overturned Roe v. Wade

The judge who blocked the FDA’s authorisation of mifepristone says he did not recall the interivew

The Supreme Court is facing a self-imposed Friday night deadline to decide whether women’s access to a widely used abortion pill will stay unchanged until a legal challenge to its Food and Drug Administration approval is resolved

The Supreme Court has given itself until midnight Friday to make an “emergency” decision on access to mifepristone, a drug used in half of all U.S. abortions. Whatever the outcome, it’s just a preliminary round in the battle over U.S. District Court Judge Matthew Kacsmaryk’s ruling earlier this month to…

The Supreme Court initially gave itself a deadline of Wednesday to decide whether women seeking access to a widely used abortion pill would face more restrictions while a court case plays out